 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | Cepheid |
| Street 1: | Vira Solelh |
| Street 2: | |
| City: | Maurens Scopont |
| Province: | |
| Post Code: | 81470 |
| Country: | France |
| Phone: | +33563825300 |
| Organization Email: | philippe.jacon@cepheid.com |
| Web Site: | http://www.cepheid.com |
| Other Online Presence: | |
|
|
||||||||||||||||||||||||||||
General Information | |
| Board Constituency: | Private sector |
| Is your organization legally registered in your country: | Yes |
| If yes, please enter your registration number: | |
| Organization Type - Primary: | Private Sector |
| Organization Type - Secondary: | Health |
| Organization Description: | |
| Molecular Diagnostic company, whose mission is: Delivering a better way to improve patient outcomes by enabling access to molecular diagnostic testing everywhere. Cepheid is the developer and maker of the Xpert MTB/RIF assay running on the polyvalent GeneXpert system. It has been rolled out in 130 countries with more than 10,000 systems and cumulatively over 35M tests through our HBDC compassionate program. We intend to pursue our commitment to participate in the End TB strategy through continuous innovations (MTB/RIF Ultra, GeneXpert Edge, GeneXpert Omni, MTB/XDR...). |
|
| Do you know about the UNHLM declaration: | |
Specializations / Areas of Work | |
|
Provision of drugs, diagnostics and commodities |
Other Organization Information | |
| Total number of staff in your organization: | 100 + |
| Number of full-time staff who are directly involved with TB: | 100 + |
| Number of part-time staff who are directly involved with TB: | 6 - 10 |
| Number of volunteers who are directly involved with TB: | 0 |
| How did you hear about the Stop TB Partnership: | Other partners |
| If you were informed or referred by another partner of the Stop TB Partnership please tell us who: | FIND |
| Why do you wish join the Stop TB Partnership: | Involvement in Stop TB Working Groups |
| Are you a member of a Stop TB national partnership: | No |
| Are you in contact with your national TB programme: | No |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| See description above. We are in contact with a large number of national TB programs. | |
Geographical Reach | |
| Which country is your headquarters located in: | United States of America |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
Afghanistan Angola Antigua and Barbuda Argentina Azerbaijan Bangladesh Belarus Belize Benin Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Central African Republic Chad Chile China Colombia Comoros Congo Cote d'Ivoire Cuba Democratic Republic of the Congo Democratic Republic of Timor-Leste Djibouti Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Eswatini Ethiopia Fiji Gabon Gambia Georgia Ghana Grenada Guatemala Guinea Guinea-Bissau Guyana Haiti Honduras India Indonesia Iran (Islamic Republic of) Iraq Jamaica Jordan Kazakhstan Kenya Kiribati Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Lithuania Madagascar Malawi Malaysia Maldives Mali Marshall Islands Mauritania Mauritius Mexico Micronesia (Federated States of) Mongolia Morocco Mozambique Myanmar Namibia Nepal Nicaragua Niger Nigeria Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines Republic of Moldova Republic of Montenegro Romania Russian Federation Rwanda Senegal Seychelles Sierra Leone Solomon Islands Somalia South Africa South Sudan Sri Lanka Sudan Suriname Tajikistan Thailand Tonga Trinidad and Tobago Tunisia Turkmenistan Uganda Ukraine United Republic of Tanzania Uruguay Uzbekistan Venezuela Viet Nam Yemen Zambia |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
TB Care Delivery: Innovations in Diagnostics Drug-Resistant TB: Development of a new MTB/XDR molecular test TB-HIV: Polyvalent GeneXpert Platform enables integration of testing. HIV EID and HIV VL are WHO Prequalified Laboratory Strengthening: GeneXpert is an easy to use molecular diagnostics technology New Diagnostics: Conitnued investments in TB molecular diagnostic tests. New TB Drugs: Active case finding with decentralized testing to allow for rapid use of new drugs in MDR environments. Research: R&D in next generation diagnostics |
|
Declaration | |
| Declaration of interests: I am employee of Cepheid, an operating Company of Danaher. As such I receive my compensation and stock options. I am a shareholder of Danaher (sticker: DHR) | |
| Application date: | May 10, 2018 |
| Last updated: | October 14, 2018 |